As of July 2025 aTyr Pharma has a market cap of $0.54 Billion USD. This makes aTyr Pharma the world's 6990th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Marketcap | Change |
---|---|---|
2025 | $0.54 B | 74.64% |
2024 | $0.31 B | 280.22% |
2023 | $82.56 M | 29.97% |
2022 | $63.53 M | -69.4% |
2021 | $0.20 B | 385.57% |
2020 | $42.75 M | 163.44% |
2019 | $16.22 M | 7.06% |
2018 | $15.15 M | -85.45% |
2017 | $0.10 B | 104.24% |
2016 | $50.99 M | -78.08% |
2015 | $0.23 B |
On Jul 28th, 2025 the market cap of aTyr Pharma was reported to be:
Name | Marketcap | Market cap differencediff. | Country |
---|---|---|---|
![]() Veracyte VCYT | $1.97 B | 260.67% | ๐บ๐ธ USA |
![]() Vertex Pharmaceuticals VRTX | $118.33 B | 21,484.33% | ๐บ๐ธ USA |